COVID-19 Impact on Global OTC Anti-Infective Products Market Insights, Forecast to 2026
Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an infectious organism or by killing the infectious organism outright.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the OTC Anti-Infective Products market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the OTC Anti-Infective Products industry.
Based on our recent survey, we have several different scenarios about the OTC Anti-Infective Products YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of OTC Anti-Infective Products will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Anti-Infective Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Anti-Infective Products market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global OTC Anti-Infective Products market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global OTC Anti-Infective Products market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global OTC Anti-Infective Products market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global OTC Anti-Infective Products market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Anti-Infective Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Anti-Infective Products market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the OTC Anti-Infective Products market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the OTC Anti-Infective Products industry.
Based on our recent survey, we have several different scenarios about the OTC Anti-Infective Products YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of OTC Anti-Infective Products will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Anti-Infective Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Anti-Infective Products market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global OTC Anti-Infective Products market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global OTC Anti-Infective Products market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global OTC Anti-Infective Products market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global OTC Anti-Infective Products market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Anti-Infective Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Anti-Infective Products market.
The following manufacturers are covered in this report:
- GlaxoSmithKline
- Merck
- Pfizer
- Novartis
- Abbott
- Sanofi
- Bristol-Myers Squibb
- Roche
- NanoViricides
- Novabay Pharmaceuticals
- Optimer Pharmaceuticals
- Basilea Pharmaceutica
- MerLion Pharma
- Antifungals
- Antiseptic
- Antiparasitics
- Hospital Pharmacies
- Drug Stores
- Retail Stores
- E-Commerce
1 STUDY COVERAGE
1.1 OTC Anti-Infective Products Product Introduction
1.2 Market Segments
1.3 Key OTC Anti-Infective Products Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type
1.4.2 Antifungals
1.4.3 Antiseptic
1.4.4 Antiparasitics
1.5 Market by Application
1.5.1 Global OTC Anti-Infective Products Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Stores
1.5.5 E-Commerce
1.6 Coronavirus Disease 2019 (Covid-19): OTC Anti-Infective Products Industry Impact
1.6.1 How the Covid-19 is Affecting the OTC Anti-Infective Products Industry
1.6.1.1 OTC Anti-Infective Products Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and OTC Anti-Infective Products Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for OTC Anti-Infective Products Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global OTC Anti-Infective Products Market Size Estimates and Forecasts
2.1.1 Global OTC Anti-Infective Products Revenue 2015-2026
2.1.2 Global OTC Anti-Infective Products Sales 2015-2026
2.2 OTC Anti-Infective Products Market Size by Region: 2020 Versus 2026
2.2.1 Global OTC Anti-Infective Products Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global OTC Anti-Infective Products Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OTC ANTI-INFECTIVE PRODUCTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 OTC Anti-Infective Products Sales by Manufacturers
3.1.1 OTC Anti-Infective Products Sales by Manufacturers (2015-2020)
3.1.2 OTC Anti-Infective Products Sales Market Share by Manufacturers (2015-2020)
3.2 OTC Anti-Infective Products Revenue by Manufacturers
3.2.1 OTC Anti-Infective Products Revenue by Manufacturers (2015-2020)
3.2.2 OTC Anti-Infective Products Revenue Share by Manufacturers (2015-2020)
3.2.3 Global OTC Anti-Infective Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Revenue in 2019
3.2.5 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 OTC Anti-Infective Products Price by Manufacturers
3.4 OTC Anti-Infective Products Manufacturing Base Distribution, Product Types
3.4.1 OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers OTC Anti-Infective Products Product Type
3.4.3 Date of International Manufacturers Enter into OTC Anti-Infective Products Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global OTC Anti-Infective Products Market Size by Type (2015-2020)
4.1.1 Global OTC Anti-Infective Products Sales by Type (2015-2020)
4.1.2 Global OTC Anti-Infective Products Revenue by Type (2015-2020)
4.1.3 OTC Anti-Infective Products Average Selling Price (ASP) by Type (2015-2026)
4.2 Global OTC Anti-Infective Products Market Size Forecast by Type (2021-2026)
4.2.1 Global OTC Anti-Infective Products Sales Forecast by Type (2021-2026)
4.2.2 Global OTC Anti-Infective Products Revenue Forecast by Type (2021-2026)
4.2.3 OTC Anti-Infective Products Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global OTC Anti-Infective Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global OTC Anti-Infective Products Market Size by Application (2015-2020)
5.1.1 Global OTC Anti-Infective Products Sales by Application (2015-2020)
5.1.2 Global OTC Anti-Infective Products Revenue by Application (2015-2020)
5.1.3 OTC Anti-Infective Products Price by Application (2015-2020)
5.2 OTC Anti-Infective Products Market Size Forecast by Application (2021-2026)
5.2.1 Global OTC Anti-Infective Products Sales Forecast by Application (2021-2026)
5.2.2 Global OTC Anti-Infective Products Revenue Forecast by Application (2021-2026)
5.2.3 Global OTC Anti-Infective Products Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America OTC Anti-Infective Products by Country
6.1.1 North America OTC Anti-Infective Products Sales by Country
6.1.2 North America OTC Anti-Infective Products Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America OTC Anti-Infective Products Market Facts & Figures by Type
6.3 North America OTC Anti-Infective Products Market Facts & Figures by Application
7 EUROPE
7.1 Europe OTC Anti-Infective Products by Country
7.1.1 Europe OTC Anti-Infective Products Sales by Country
7.1.2 Europe OTC Anti-Infective Products Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe OTC Anti-Infective Products Market Facts & Figures by Type
7.3 Europe OTC Anti-Infective Products Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific OTC Anti-Infective Products by Region
8.1.1 Asia Pacific OTC Anti-Infective Products Sales by Region
8.1.2 Asia Pacific OTC Anti-Infective Products Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Type
8.3 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America OTC Anti-Infective Products by Country
9.1.1 Latin America OTC Anti-Infective Products Sales by Country
9.1.2 Latin America OTC Anti-Infective Products Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America OTC Anti-Infective Products Market Facts & Figures by Type
9.3 Central & South America OTC Anti-Infective Products Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa OTC Anti-Infective Products by Country
10.1.1 Middle East and Africa OTC Anti-Infective Products Sales by Country
10.1.2 Middle East and Africa OTC Anti-Infective Products Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Type
10.3 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description, Business Overview and Total Revenue
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck OTC Anti-Infective Products Products Offered
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer OTC Anti-Infective Products Products Offered
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description, Business Overview and Total Revenue
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis OTC Anti-Infective Products Products Offered
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Description, Business Overview and Total Revenue
11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbott OTC Anti-Infective Products Products Offered
11.5.5 Abbott Recent Development
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description, Business Overview and Total Revenue
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi OTC Anti-Infective Products Products Offered
11.6.5 Sanofi Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb OTC Anti-Infective Products Products Offered
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Description, Business Overview and Total Revenue
11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Roche OTC Anti-Infective Products Products Offered
11.8.5 Roche Recent Development
11.9 NanoViricides
11.9.1 NanoViricides Corporation Information
11.9.2 NanoViricides Description, Business Overview and Total Revenue
11.9.3 NanoViricides Sales, Revenue and Gross Margin (2015-2020)
11.9.4 NanoViricides OTC Anti-Infective Products Products Offered
11.9.5 NanoViricides Recent Development
11.10 Novabay Pharmaceuticals
11.10.1 Novabay Pharmaceuticals Corporation Information
11.10.2 Novabay Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Novabay Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novabay Pharmaceuticals OTC Anti-Infective Products Products Offered
11.10.5 Novabay Pharmaceuticals Recent Development
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.12 Basilea Pharmaceutica
11.12.1 Basilea Pharmaceutica Corporation Information
11.12.2 Basilea Pharmaceutica Description, Business Overview and Total Revenue
11.12.3 Basilea Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Basilea Pharmaceutica Products Offered
11.12.5 Basilea Pharmaceutica Recent Development
11.13 MerLion Pharma
11.13.1 MerLion Pharma Corporation Information
11.13.2 MerLion Pharma Description, Business Overview and Total Revenue
11.13.3 MerLion Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 MerLion Pharma Products Offered
11.13.5 MerLion Pharma Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 OTC Anti-Infective Products Market Estimates and Projections by Region
12.1.1 Global OTC Anti-Infective Products Sales Forecast by Regions 2021-2026
12.1.2 Global OTC Anti-Infective Products Revenue Forecast by Regions 2021-2026
12.2 North America OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.2.1 North America: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.2.2 North America: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.2.3 North America: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
12.3 Europe OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.3.1 Europe: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.3.2 Europe: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.3.3 Europe: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.4.2 Asia Pacific: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: OTC Anti-Infective Products Market Size Forecast by Region (2021-2026)
12.5 Latin America OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.5.1 Latin America: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.5.2 Latin America: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.5.3 Latin America: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key OTC Anti-Infective Products Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 OTC Anti-Infective Products Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 OTC Anti-Infective Products Product Introduction
1.2 Market Segments
1.3 Key OTC Anti-Infective Products Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type
1.4.2 Antifungals
1.4.3 Antiseptic
1.4.4 Antiparasitics
1.5 Market by Application
1.5.1 Global OTC Anti-Infective Products Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Stores
1.5.5 E-Commerce
1.6 Coronavirus Disease 2019 (Covid-19): OTC Anti-Infective Products Industry Impact
1.6.1 How the Covid-19 is Affecting the OTC Anti-Infective Products Industry
1.6.1.1 OTC Anti-Infective Products Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and OTC Anti-Infective Products Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for OTC Anti-Infective Products Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global OTC Anti-Infective Products Market Size Estimates and Forecasts
2.1.1 Global OTC Anti-Infective Products Revenue 2015-2026
2.1.2 Global OTC Anti-Infective Products Sales 2015-2026
2.2 OTC Anti-Infective Products Market Size by Region: 2020 Versus 2026
2.2.1 Global OTC Anti-Infective Products Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global OTC Anti-Infective Products Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OTC ANTI-INFECTIVE PRODUCTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 OTC Anti-Infective Products Sales by Manufacturers
3.1.1 OTC Anti-Infective Products Sales by Manufacturers (2015-2020)
3.1.2 OTC Anti-Infective Products Sales Market Share by Manufacturers (2015-2020)
3.2 OTC Anti-Infective Products Revenue by Manufacturers
3.2.1 OTC Anti-Infective Products Revenue by Manufacturers (2015-2020)
3.2.2 OTC Anti-Infective Products Revenue Share by Manufacturers (2015-2020)
3.2.3 Global OTC Anti-Infective Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Revenue in 2019
3.2.5 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 OTC Anti-Infective Products Price by Manufacturers
3.4 OTC Anti-Infective Products Manufacturing Base Distribution, Product Types
3.4.1 OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers OTC Anti-Infective Products Product Type
3.4.3 Date of International Manufacturers Enter into OTC Anti-Infective Products Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global OTC Anti-Infective Products Market Size by Type (2015-2020)
4.1.1 Global OTC Anti-Infective Products Sales by Type (2015-2020)
4.1.2 Global OTC Anti-Infective Products Revenue by Type (2015-2020)
4.1.3 OTC Anti-Infective Products Average Selling Price (ASP) by Type (2015-2026)
4.2 Global OTC Anti-Infective Products Market Size Forecast by Type (2021-2026)
4.2.1 Global OTC Anti-Infective Products Sales Forecast by Type (2021-2026)
4.2.2 Global OTC Anti-Infective Products Revenue Forecast by Type (2021-2026)
4.2.3 OTC Anti-Infective Products Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global OTC Anti-Infective Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global OTC Anti-Infective Products Market Size by Application (2015-2020)
5.1.1 Global OTC Anti-Infective Products Sales by Application (2015-2020)
5.1.2 Global OTC Anti-Infective Products Revenue by Application (2015-2020)
5.1.3 OTC Anti-Infective Products Price by Application (2015-2020)
5.2 OTC Anti-Infective Products Market Size Forecast by Application (2021-2026)
5.2.1 Global OTC Anti-Infective Products Sales Forecast by Application (2021-2026)
5.2.2 Global OTC Anti-Infective Products Revenue Forecast by Application (2021-2026)
5.2.3 Global OTC Anti-Infective Products Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America OTC Anti-Infective Products by Country
6.1.1 North America OTC Anti-Infective Products Sales by Country
6.1.2 North America OTC Anti-Infective Products Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America OTC Anti-Infective Products Market Facts & Figures by Type
6.3 North America OTC Anti-Infective Products Market Facts & Figures by Application
7 EUROPE
7.1 Europe OTC Anti-Infective Products by Country
7.1.1 Europe OTC Anti-Infective Products Sales by Country
7.1.2 Europe OTC Anti-Infective Products Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe OTC Anti-Infective Products Market Facts & Figures by Type
7.3 Europe OTC Anti-Infective Products Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific OTC Anti-Infective Products by Region
8.1.1 Asia Pacific OTC Anti-Infective Products Sales by Region
8.1.2 Asia Pacific OTC Anti-Infective Products Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Type
8.3 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America OTC Anti-Infective Products by Country
9.1.1 Latin America OTC Anti-Infective Products Sales by Country
9.1.2 Latin America OTC Anti-Infective Products Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America OTC Anti-Infective Products Market Facts & Figures by Type
9.3 Central & South America OTC Anti-Infective Products Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa OTC Anti-Infective Products by Country
10.1.1 Middle East and Africa OTC Anti-Infective Products Sales by Country
10.1.2 Middle East and Africa OTC Anti-Infective Products Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Type
10.3 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description, Business Overview and Total Revenue
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck OTC Anti-Infective Products Products Offered
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer OTC Anti-Infective Products Products Offered
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description, Business Overview and Total Revenue
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis OTC Anti-Infective Products Products Offered
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Description, Business Overview and Total Revenue
11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abbott OTC Anti-Infective Products Products Offered
11.5.5 Abbott Recent Development
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description, Business Overview and Total Revenue
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi OTC Anti-Infective Products Products Offered
11.6.5 Sanofi Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb OTC Anti-Infective Products Products Offered
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Description, Business Overview and Total Revenue
11.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Roche OTC Anti-Infective Products Products Offered
11.8.5 Roche Recent Development
11.9 NanoViricides
11.9.1 NanoViricides Corporation Information
11.9.2 NanoViricides Description, Business Overview and Total Revenue
11.9.3 NanoViricides Sales, Revenue and Gross Margin (2015-2020)
11.9.4 NanoViricides OTC Anti-Infective Products Products Offered
11.9.5 NanoViricides Recent Development
11.10 Novabay Pharmaceuticals
11.10.1 Novabay Pharmaceuticals Corporation Information
11.10.2 Novabay Pharmaceuticals Description, Business Overview and Total Revenue
11.10.3 Novabay Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novabay Pharmaceuticals OTC Anti-Infective Products Products Offered
11.10.5 Novabay Pharmaceuticals Recent Development
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.12 Basilea Pharmaceutica
11.12.1 Basilea Pharmaceutica Corporation Information
11.12.2 Basilea Pharmaceutica Description, Business Overview and Total Revenue
11.12.3 Basilea Pharmaceutica Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Basilea Pharmaceutica Products Offered
11.12.5 Basilea Pharmaceutica Recent Development
11.13 MerLion Pharma
11.13.1 MerLion Pharma Corporation Information
11.13.2 MerLion Pharma Description, Business Overview and Total Revenue
11.13.3 MerLion Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 MerLion Pharma Products Offered
11.13.5 MerLion Pharma Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 OTC Anti-Infective Products Market Estimates and Projections by Region
12.1.1 Global OTC Anti-Infective Products Sales Forecast by Regions 2021-2026
12.1.2 Global OTC Anti-Infective Products Revenue Forecast by Regions 2021-2026
12.2 North America OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.2.1 North America: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.2.2 North America: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.2.3 North America: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
12.3 Europe OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.3.1 Europe: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.3.2 Europe: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.3.3 Europe: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.4.2 Asia Pacific: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: OTC Anti-Infective Products Market Size Forecast by Region (2021-2026)
12.5 Latin America OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.5.1 Latin America: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.5.2 Latin America: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.5.3 Latin America: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa OTC Anti-Infective Products Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: OTC Anti-Infective Products Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: OTC Anti-Infective Products Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: OTC Anti-Infective Products Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key OTC Anti-Infective Products Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 OTC Anti-Infective Products Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. OTC Anti-Infective Products Market Segments
Table 2. Ranking of Global Top OTC Anti-Infective Products Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global OTC Anti-Infective Products Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Antifungals
Table 5. Major Manufacturers of Antiseptic
Table 6. Major Manufacturers of Antiparasitics
Table 7. COVID-19 Impact Global Market: (Four OTC Anti-Infective Products Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for OTC Anti-Infective Products Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for OTC Anti-Infective Products Players to Combat Covid-19 Impact
Table 12. Global OTC Anti-Infective Products Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global OTC Anti-Infective Products Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global OTC Anti-Infective Products Sales by Regions 2015-2020 (K Units)
Table 15. Global OTC Anti-Infective Products Sales Market Share by Regions (2015-2020)
Table 16. Global OTC Anti-Infective Products Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global OTC Anti-Infective Products Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global OTC Anti-Infective Products Sales Share by Manufacturers (2015-2020)
Table 19. Global OTC Anti-Infective Products Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Anti-Infective Products as of 2019)
Table 21. OTC Anti-Infective Products Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. OTC Anti-Infective Products Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers OTC Anti-Infective Products Price (2015-2020) (USD/Unit)
Table 24. OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers OTC Anti-Infective Products Product Type
Table 26. Date of International Manufacturers Enter into OTC Anti-Infective Products Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 29. Global OTC Anti-Infective Products Sales Share by Type (2015-2020)
Table 30. Global OTC Anti-Infective Products Revenue by Type (2015-2020) (US$ Million)
Table 31. Global OTC Anti-Infective Products Revenue Share by Type (2015-2020)
Table 32. OTC Anti-Infective Products Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 34. Global OTC Anti-Infective Products Sales Share by Application (2015-2020)
Table 35. North America OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 36. North America OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 37. North America OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 38. North America OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 39. North America OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 40. North America OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 41. North America OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 42. North America OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 43. Europe OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 44. Europe OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 45. Europe OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 47. Europe OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 48. Europe OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 49. Europe OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 50. Europe OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific OTC Anti-Infective Products Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific OTC Anti-Infective Products Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 59. Latin America OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 60. Latin America OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 63. Latin America OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 64. Latin America OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 65. Latin America OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 66. Latin America OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Major Businesses
Table 77. GlaxoSmithKline OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Major Businesses
Table 82. Merck OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck Product
Table 84. Merck Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Major Businesses
Table 87. Pfizer OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer Product
Table 89. Pfizer Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Major Businesses
Table 92. Novartis OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Product
Table 94. Novartis Recent Development
Table 95. Abbott Corporation Information
Table 96. Abbott Description and Major Businesses
Table 97. Abbott OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Abbott Product
Table 99. Abbott Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Major Businesses
Table 102. Sanofi OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sanofi Product
Table 104. Sanofi Recent Development
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Major Businesses
Table 107. Bristol-Myers Squibb OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Bristol-Myers Squibb Product
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Roche Corporation Information
Table 111. Roche Description and Major Businesses
Table 112. Roche OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Roche Product
Table 114. Roche Recent Development
Table 115. NanoViricides Corporation Information
Table 116. NanoViricides Description and Major Businesses
Table 117. NanoViricides OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. NanoViricides Product
Table 119. NanoViricides Recent Development
Table 120. Novabay Pharmaceuticals Corporation Information
Table 121. Novabay Pharmaceuticals Description and Major Businesses
Table 122. Novabay Pharmaceuticals OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Novabay Pharmaceuticals Product
Table 124. Novabay Pharmaceuticals Recent Development
Table 125. Optimer Pharmaceuticals Corporation Information
Table 126. Optimer Pharmaceuticals Description and Major Businesses
Table 127. Optimer Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Optimer Pharmaceuticals Product
Table 129. Optimer Pharmaceuticals Recent Development
Table 130. Basilea Pharmaceutica Corporation Information
Table 131. Basilea Pharmaceutica Description and Major Businesses
Table 132. Basilea Pharmaceutica OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Basilea Pharmaceutica Product
Table 134. Basilea Pharmaceutica Recent Development
Table 135. MerLion Pharma Corporation Information
Table 136. MerLion Pharma Description and Major Businesses
Table 137. MerLion Pharma OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. MerLion Pharma Product
Table 139. MerLion Pharma Recent Development
Table 140. Global OTC Anti-Infective Products Sales Forecast by Regions (2021-2026) (K Units)
Table 141. Global OTC Anti-Infective Products Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global OTC Anti-Infective Products Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global OTC Anti-Infective Products Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 145. North America: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 147. Europe: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: OTC Anti-Infective Products Sales Forecast by Region (2021-2026) (K Units)
Table 149. Asia Pacific: OTC Anti-Infective Products Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 151. Latin America: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 153. Middle East and Africa: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key OTC Anti-Infective Products Players
Table 158. OTC Anti-Infective Products Customers List
Table 159. OTC Anti-Infective Products Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
Table 1. OTC Anti-Infective Products Market Segments
Table 2. Ranking of Global Top OTC Anti-Infective Products Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global OTC Anti-Infective Products Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Antifungals
Table 5. Major Manufacturers of Antiseptic
Table 6. Major Manufacturers of Antiparasitics
Table 7. COVID-19 Impact Global Market: (Four OTC Anti-Infective Products Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for OTC Anti-Infective Products Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for OTC Anti-Infective Products Players to Combat Covid-19 Impact
Table 12. Global OTC Anti-Infective Products Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global OTC Anti-Infective Products Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global OTC Anti-Infective Products Sales by Regions 2015-2020 (K Units)
Table 15. Global OTC Anti-Infective Products Sales Market Share by Regions (2015-2020)
Table 16. Global OTC Anti-Infective Products Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global OTC Anti-Infective Products Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global OTC Anti-Infective Products Sales Share by Manufacturers (2015-2020)
Table 19. Global OTC Anti-Infective Products Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Anti-Infective Products as of 2019)
Table 21. OTC Anti-Infective Products Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. OTC Anti-Infective Products Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers OTC Anti-Infective Products Price (2015-2020) (USD/Unit)
Table 24. OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers OTC Anti-Infective Products Product Type
Table 26. Date of International Manufacturers Enter into OTC Anti-Infective Products Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 29. Global OTC Anti-Infective Products Sales Share by Type (2015-2020)
Table 30. Global OTC Anti-Infective Products Revenue by Type (2015-2020) (US$ Million)
Table 31. Global OTC Anti-Infective Products Revenue Share by Type (2015-2020)
Table 32. OTC Anti-Infective Products Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 34. Global OTC Anti-Infective Products Sales Share by Application (2015-2020)
Table 35. North America OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 36. North America OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 37. North America OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 38. North America OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 39. North America OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 40. North America OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 41. North America OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 42. North America OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 43. Europe OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 44. Europe OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 45. Europe OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 47. Europe OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 48. Europe OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 49. Europe OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 50. Europe OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific OTC Anti-Infective Products Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific OTC Anti-Infective Products Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 59. Latin America OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 60. Latin America OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 63. Latin America OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 64. Latin America OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 65. Latin America OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 66. Latin America OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa OTC Anti-Infective Products Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa OTC Anti-Infective Products Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa OTC Anti-Infective Products Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Major Businesses
Table 77. GlaxoSmithKline OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Major Businesses
Table 82. Merck OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck Product
Table 84. Merck Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Major Businesses
Table 87. Pfizer OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer Product
Table 89. Pfizer Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Major Businesses
Table 92. Novartis OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Product
Table 94. Novartis Recent Development
Table 95. Abbott Corporation Information
Table 96. Abbott Description and Major Businesses
Table 97. Abbott OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Abbott Product
Table 99. Abbott Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Major Businesses
Table 102. Sanofi OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sanofi Product
Table 104. Sanofi Recent Development
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Major Businesses
Table 107. Bristol-Myers Squibb OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Bristol-Myers Squibb Product
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Roche Corporation Information
Table 111. Roche Description and Major Businesses
Table 112. Roche OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Roche Product
Table 114. Roche Recent Development
Table 115. NanoViricides Corporation Information
Table 116. NanoViricides Description and Major Businesses
Table 117. NanoViricides OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. NanoViricides Product
Table 119. NanoViricides Recent Development
Table 120. Novabay Pharmaceuticals Corporation Information
Table 121. Novabay Pharmaceuticals Description and Major Businesses
Table 122. Novabay Pharmaceuticals OTC Anti-Infective Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Novabay Pharmaceuticals Product
Table 124. Novabay Pharmaceuticals Recent Development
Table 125. Optimer Pharmaceuticals Corporation Information
Table 126. Optimer Pharmaceuticals Description and Major Businesses
Table 127. Optimer Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Optimer Pharmaceuticals Product
Table 129. Optimer Pharmaceuticals Recent Development
Table 130. Basilea Pharmaceutica Corporation Information
Table 131. Basilea Pharmaceutica Description and Major Businesses
Table 132. Basilea Pharmaceutica OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Basilea Pharmaceutica Product
Table 134. Basilea Pharmaceutica Recent Development
Table 135. MerLion Pharma Corporation Information
Table 136. MerLion Pharma Description and Major Businesses
Table 137. MerLion Pharma OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. MerLion Pharma Product
Table 139. MerLion Pharma Recent Development
Table 140. Global OTC Anti-Infective Products Sales Forecast by Regions (2021-2026) (K Units)
Table 141. Global OTC Anti-Infective Products Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global OTC Anti-Infective Products Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global OTC Anti-Infective Products Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 145. North America: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 147. Europe: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: OTC Anti-Infective Products Sales Forecast by Region (2021-2026) (K Units)
Table 149. Asia Pacific: OTC Anti-Infective Products Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 151. Latin America: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: OTC Anti-Infective Products Sales Forecast by Country (2021-2026) (K Units)
Table 153. Middle East and Africa: OTC Anti-Infective Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key OTC Anti-Infective Products Players
Table 158. OTC Anti-Infective Products Customers List
Table 159. OTC Anti-Infective Products Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. OTC Anti-Infective Products Product Picture
Figure 2. Global OTC Anti-Infective Products Sales Market Share by Type in 2020 & 2026
Figure 3. Antifungals Product Picture
Figure 4. Antiseptic Product Picture
Figure 5. Antiparasitics Product Picture
Figure 6. Global OTC Anti-Infective Products Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Drug Stores
Figure 9. Retail Stores
Figure 10. E-Commerce
Figure 11. OTC Anti-Infective Products Report Years Considered
Figure 12. Global OTC Anti-Infective Products Market Size 2015-2026 (US$ Million)
Figure 13. Global OTC Anti-Infective Products Sales 2015-2026 (K Units)
Figure 14. Global OTC Anti-Infective Products Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global OTC Anti-Infective Products Sales Market Share by Region (2015-2020)
Figure 16. Global OTC Anti-Infective Products Sales Market Share by Region in 2019
Figure 17. Global OTC Anti-Infective Products Revenue Market Share by Region (2015-2020)
Figure 18. Global OTC Anti-Infective Products Revenue Market Share by Region in 2019
Figure 19. Global OTC Anti-Infective Products Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by OTC Anti-Infective Products Revenue in 2019
Figure 21. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Figure 23. Global OTC Anti-Infective Products Sales Market Share by Type in 2019
Figure 24. Global OTC Anti-Infective Products Revenue Market Share by Type (2015-2020)
Figure 25. Global OTC Anti-Infective Products Revenue Market Share by Type in 2019
Figure 26. Global OTC Anti-Infective Products Market Share by Price Range (2015-2020)
Figure 27. Global OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Figure 28. Global OTC Anti-Infective Products Sales Market Share by Application in 2019
Figure 29. Global OTC Anti-Infective Products Revenue Market Share by Application (2015-2020)
Figure 30. Global OTC Anti-Infective Products Revenue Market Share by Application in 2019
Figure 31. North America OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America OTC Anti-Infective Products Sales Market Share by Country in 2019
Figure 34. North America OTC Anti-Infective Products Revenue Market Share by Country in 2019
Figure 35. U.S. OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America OTC Anti-Infective Products Market Share by Type in 2019
Figure 40. North America OTC Anti-Infective Products Market Share by Application in 2019
Figure 41. Europe OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe OTC Anti-Infective Products Sales Market Share by Country in 2019
Figure 44. Europe OTC Anti-Infective Products Revenue Market Share by Country in 2019
Figure 45. Germany OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 48. France OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe OTC Anti-Infective Products Market Share by Type in 2019
Figure 56. Europe OTC Anti-Infective Products Market Share by Application in 2019
Figure 57. Asia Pacific OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region in 2019
Figure 60. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region in 2019
Figure 61. China OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 62. China OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 68. India OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific OTC Anti-Infective Products Market Share by Type in 2019
Figure 84. Asia Pacific OTC Anti-Infective Products Market Share by Application in 2019
Figure 85. Latin America OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America OTC Anti-Infective Products Sales Market Share by Country in 2019
Figure 88. Latin America OTC Anti-Infective Products Revenue Market Share by Country in 2019
Figure 89. Mexico OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America OTC Anti-Infective Products Market Share by Type in 2019
Figure 96. Latin America OTC Anti-Infective Products Market Share by Application in 2019
Figure 97. Middle East and Africa OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country in 2019
Figure 100. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country in 2019
Figure 101. Turkey OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa OTC Anti-Infective Products Market Share by Type in 2019
Figure 108. Middle East and Africa OTC Anti-Infective Products Market Share by Application in 2019
Figure 109. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. NanoViricides Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Novabay Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Optimer Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Basilea Pharmaceutica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. MerLion Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. North America OTC Anti-Infective Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. North America OTC Anti-Infective Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Europe OTC Anti-Infective Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Europe OTC Anti-Infective Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Asia Pacific OTC Anti-Infective Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Asia Pacific OTC Anti-Infective Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Latin America OTC Anti-Infective Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 129. Latin America OTC Anti-Infective Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Middle East and Africa OTC Anti-Infective Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 131. Middle East and Africa OTC Anti-Infective Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Porter's Five Forces Analysis
Figure 133. Channels of Distribution
Figure 134. Distributors Profiles
Figure 135. Bottom-up and Top-down Approaches for This Report
Figure 136. Data Triangulation
Figure 137. Key Executives Interviewed
Figure 1. OTC Anti-Infective Products Product Picture
Figure 2. Global OTC Anti-Infective Products Sales Market Share by Type in 2020 & 2026
Figure 3. Antifungals Product Picture
Figure 4. Antiseptic Product Picture
Figure 5. Antiparasitics Product Picture
Figure 6. Global OTC Anti-Infective Products Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Drug Stores
Figure 9. Retail Stores
Figure 10. E-Commerce
Figure 11. OTC Anti-Infective Products Report Years Considered
Figure 12. Global OTC Anti-Infective Products Market Size 2015-2026 (US$ Million)
Figure 13. Global OTC Anti-Infective Products Sales 2015-2026 (K Units)
Figure 14. Global OTC Anti-Infective Products Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global OTC Anti-Infective Products Sales Market Share by Region (2015-2020)
Figure 16. Global OTC Anti-Infective Products Sales Market Share by Region in 2019
Figure 17. Global OTC Anti-Infective Products Revenue Market Share by Region (2015-2020)
Figure 18. Global OTC Anti-Infective Products Revenue Market Share by Region in 2019
Figure 19. Global OTC Anti-Infective Products Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by OTC Anti-Infective Products Revenue in 2019
Figure 21. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global OTC Anti-Infective Products Sales Market Share by Type (2015-2020)
Figure 23. Global OTC Anti-Infective Products Sales Market Share by Type in 2019
Figure 24. Global OTC Anti-Infective Products Revenue Market Share by Type (2015-2020)
Figure 25. Global OTC Anti-Infective Products Revenue Market Share by Type in 2019
Figure 26. Global OTC Anti-Infective Products Market Share by Price Range (2015-2020)
Figure 27. Global OTC Anti-Infective Products Sales Market Share by Application (2015-2020)
Figure 28. Global OTC Anti-Infective Products Sales Market Share by Application in 2019
Figure 29. Global OTC Anti-Infective Products Revenue Market Share by Application (2015-2020)
Figure 30. Global OTC Anti-Infective Products Revenue Market Share by Application in 2019
Figure 31. North America OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America OTC Anti-Infective Products Sales Market Share by Country in 2019
Figure 34. North America OTC Anti-Infective Products Revenue Market Share by Country in 2019
Figure 35. U.S. OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America OTC Anti-Infective Products Market Share by Type in 2019
Figure 40. North America OTC Anti-Infective Products Market Share by Application in 2019
Figure 41. Europe OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe OTC Anti-Infective Products Sales Market Share by Country in 2019
Figure 44. Europe OTC Anti-Infective Products Revenue Market Share by Country in 2019
Figure 45. Germany OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 48. France OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe OTC Anti-Infective Products Market Share by Type in 2019
Figure 56. Europe OTC Anti-Infective Products Market Share by Application in 2019
Figure 57. Asia Pacific OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region in 2019
Figure 60. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region in 2019
Figure 61. China OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 62. China OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 68. India OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific OTC Anti-Infective Products Market Share by Type in 2019
Figure 84. Asia Pacific OTC Anti-Infective Products Market Share by Application in 2019
Figure 85. Latin America OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America OTC Anti-Infective Products Sales Market Share by Country in 2019
Figure 88. Latin America OTC Anti-Infective Products Revenue Market Share by Country in 2019
Figure 89. Mexico OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America OTC Anti-Infective Products Market Share by Type in 2019
Figure 96. Latin America OTC Anti-Infective Products Market Share by Application in 2019
Figure 97. Middle East and Africa OTC Anti-Infective Products Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa OTC Anti-Infective Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country in 2019
Figure 100. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country in 2019
Figure 101. Turkey OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E OTC Anti-Infective Products Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E OTC Anti-Infective Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa OTC Anti-Infective Products Market Share by Type in 2019
Figure 108. Middle East and Africa OTC Anti-Infective Products Market Share by Application in 2019
Figure 109. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. NanoViricides Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Novabay Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Optimer Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Basilea Pharmaceutica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. MerLion Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. North America OTC Anti-Infective Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. North America OTC Anti-Infective Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Europe OTC Anti-Infective Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Europe OTC Anti-Infective Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Asia Pacific OTC Anti-Infective Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Asia Pacific OTC Anti-Infective Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Latin America OTC Anti-Infective Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 129. Latin America OTC Anti-Infective Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Middle East and Africa OTC Anti-Infective Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 131. Middle East and Africa OTC Anti-Infective Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Porter's Five Forces Analysis
Figure 133. Channels of Distribution
Figure 134. Distributors Profiles
Figure 135. Bottom-up and Top-down Approaches for This Report
Figure 136. Data Triangulation
Figure 137. Key Executives Interviewed
